A226950 Share Price Performance
₩91,700.00
73740.00 (410.58%)
Price ₩91,700.00
Share Price₩91,700.00
Is OliX Pharmaceuticals (KOSDAQ:226950) Using Too Much Debt?
Jul 07
OliX Pharmaceuticals, Inc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A226950 Community Narratives
There are no narratives available yet.
Recent A226950 News & Updates
Is OliX Pharmaceuticals (KOSDAQ:226950) Using Too Much Debt?
Mar 21The Price Is Right For OliX Pharmaceuticals, Inc (KOSDAQ:226950) Even After Diving 27%
Jan 29OliX Pharmaceuticals, Inc (KOSDAQ:226950) Looks Just Right With A 34% Price Jump
Dec 07OliX Pharmaceuticals (KOSDAQ:226950) Is Making Moderate Use Of Debt
Nov 15OliX Pharmaceuticals, Inc (KOSDAQ:226950) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Oct 09OliX Pharmaceuticals, Inc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.24k
- Gross Margin
- 96.20%
- Net Profit Margin
- -598.92%
- Debt/Equity Ratio
- 116.8%
OliX Pharmaceuticals, Inc Competitors
Snowflake Analysis
About A226950
- Founded
- 2010
- Employees
- 66
- CEO
- WebsiteView website
OliX Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company’s products pipeline includes OLX101A for skin scar; OLX104C for androgenic alopecia; OLX301A for age-related macular degeneration; OLX702A for metabolic dysfunction-associated steatohepatitis; OLX703A for hepatitis; and OLX301D for subretinal fibrosis. The company has a license and collaboration agreement with Hansoh Pharmaceuticals; development collaboration with Korea Institute of Technology; and research collaboration with the University of Virginia. The company was formerly known as Biomolecular Therapeutics Inc. OliX Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Suwon-si, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.3%
- 3 Months: 13.9%
- 1 Year: 32.6%
- Year to Date: 44.6%
The market has climbed 4.5% in the last 7 days, lead by the Information Technology sector with a gain of 8.8%. As for the past 12 months, the market is up 34%. Earnings are forecast to grow by 24% annually. Market details ›